VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment of Nagihan ŞENGÜL KARPUZ to the company’s Board of Directors.
Nagihan Şengül Karpuz has been appointed Board Member of VSY Biotechnology. She began her carrier at E&Y and has spent most of her career at Yıldız Holding, working in various areas related to tax compliance, tax policies, IFRS reporting, financial consolidation, global insurance management, budget, accounting and financial performance reporting processes. She recently has founded NSK Strategic Consultancy Company after leaving her latest role as Vice President of Financial Affairs of of Yıldız Holding.
Nagihan holds a degree in Economics from Middle East Technical University and MBA in Business Administration from Yeditepe University.
“VSY Biotechnology provides me with an exciting opportunity to work with a highly committed and professional executive team to deliver on an ambitious global growth strategy,” she said.
VSY Biotechnology Chairman Dr. Ercan Varlibas said: “Nagihan’s wide experience at companies and her strong background in audit and financial control will be valuable assets in the next stages of VSY Biotechnology’s development. Everyone at VSY Biotechnology looks forward to welcoming her to the team.”
Nagihan Şengül Karpuz has been appointed Board Member of VSY Biotechnology. She began her carrier at E&Y and has spent most of her career at Yıldız Holding, working in various areas related to tax compliance, tax policies, IFRS reporting, financial consolidation, global insurance management, budget, accounting and financial performance reporting processes. She recently has founded NSK Strategic Consultancy Company after leaving her latest role as Vice President of Financial Affairs of of Yıldız Holding.
Nagihan holds a degree in Economics from Middle East Technical University and MBA in Business Administration from Yeditepe University.
“VSY Biotechnology provides me with an exciting opportunity to work with a highly committed and professional executive team to deliver on an ambitious global growth strategy,” she said.
VSY Biotechnology Chairman Dr. Ercan Varlibas said: “Nagihan’s wide experience at companies and her strong background in audit and financial control will be valuable assets in the next stages of VSY Biotechnology’s development. Everyone at VSY Biotechnology looks forward to welcoming her to the team.”
